Answers are grounded in this paper and cite their sources.
These studies suggest that LA improves SDN, in significant part by reducing the effects of oxidative stress. The drug may have potential in the treatment of human diabetic neuropathy.
No takes yet. Share an insight, caveat, or question.
Nagamatsu et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: